Japan's Pola Orbis lifting dividend on hit anti-wrinkle cream

Target payout for 2017 amounts to 40% year-on-year increase

1130N Pola

Sales of Wrinkle Shot Serum cream reached 11.2 billion yen in January-September, just over 30% above initial expectations.

TOKYO -- Japanese cosmetics company Pola Orbis Holdings upgraded its year-end dividend outlook Wednesday, projecting an annual payout effectively 40% above the previous year's, thanks to robust earnings driven by a popular wrinkle-fighting cream.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.